Cargando…
HER2+ breast cancer treatment and cardiotoxicity: monitoring and management
BACKGROUND: Breast cancer is a leading cause of death for women worldwide, with incidence increasing in lower-income countries. For patients with human epidermal growth factor receptor-2-positive (HER2+) breast cancer, widespread availability of several agents targeting the HER2 receptor has resulte...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661020/ https://www.ncbi.nlm.nih.gov/pubmed/31165940 http://dx.doi.org/10.1007/s10549-019-05303-y |